| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/31/2005 | EP0941333B1 Immunogenic detoxified mutant e. coli lt-a toxin |
| 08/31/2005 | EP0869813B1 Use of beta-interferons to treat restenosis |
| 08/31/2005 | EP0786002B1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 08/31/2005 | CN1662703A Appts. and method for extracting kraft paper pulp and atuomatically defibering |
| 08/31/2005 | CN1662664A Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions |
| 08/31/2005 | CN1662663A DNA enzyme to inhibit plasminogen activator inhibitor-1 |
| 08/31/2005 | CN1662558A Antibodies specific for human cd22 and their therapeutic anddiagnostic uses |
| 08/31/2005 | CN1662555A Chimeric antagonist ANTH1 |
| 08/31/2005 | CN1662552A Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 08/31/2005 | CN1662551A Antagonistic peptides of prostaglandin e2 receptor subtype ep4 |
| 08/31/2005 | CN1662548A Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 08/31/2005 | CN1662493A Ring -substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 08/31/2005 | CN1662280A Method and apparatus for ultrasound treatment of connective tissue |
| 08/31/2005 | CN1662262A Decoys for treating and/or preventing Th2 cytokine-related allergic diseases, GATA3 mutant proteins and pharmaceutical compositions comprising the decoys and the proteins |
| 08/31/2005 | CN1662260A Process for producing sustained-release composition |
| 08/31/2005 | CN1662255A Use of substances for treating tumors |
| 08/31/2005 | CN1662252A Acidic insulin preparations with improved stability |
| 08/31/2005 | CN1662251A Adjuvant enhanced immunotherapy |
| 08/31/2005 | CN1662250A Aqueous preparation containing oligopeptides and etherified cyclodextrin |
| 08/31/2005 | CN1662249A Osteopontin, oligodendrocytes and myelination |
| 08/31/2005 | CN1662228A Compositions and method for transmucosal drug delivery and cryoprotection |
| 08/31/2005 | CN1662142A Oil body associated protein compositions, methods of and use thereof for reducing the risk of cardiovascular disease |
| 08/31/2005 | CN1661373A New target drone of medication for anti hepatitis b virus and application |
| 08/31/2005 | CN1661109A Novel targets for obesity from skeletal muscle |
| 08/31/2005 | CN1661036A Method for preparing interferon of white blood cells of dogs |
| 08/31/2005 | CN1661035A Method for preparing leukocyte interferon of pig |
| 08/31/2005 | CN1661019A Method for producing recombined endothelium chalone in bacillus colis and application |
| 08/31/2005 | CN1660911A Connective tissue growth factor fragments and methods and uses thereof |
| 08/31/2005 | CN1660899A GP thymosin alpha 1 and preparation method |
| 08/31/2005 | CN1660895A Synthesized polypeptide and application |
| 08/31/2005 | CN1660891A Small peptide sequence of combined site between envelope protein E2 of close hepatitis C virus and human CD81 |
| 08/31/2005 | CN1660889A Low hemolytic antibacterial peptide and its application |
| 08/31/2005 | CN1660888A Peptide of decreasing blood pressure of protein of acetes chinensis, preparing method and application |
| 08/31/2005 | CN1660444A Immunity coupler of containing monoclonal antibody Fab' segment of anti TV type collagenase poly glutamic acid-blemycin A5 |
| 08/31/2005 | CN1660427A Extracorporeal photopheresis in combination with anti-tnf treatment |
| 08/31/2005 | CN1660426A Methods for inhibiting brain tumor growth |
| 08/31/2005 | CN1660420A Compound combination of Chinese traditional medicine in use for lowering viscosity of whole blood, thrombolysis and reducing blood fat |
| 08/31/2005 | CN1660419A Adsorbent of compound urease for urea nitrogen and preparing method |
| 08/31/2005 | CN1660418A New type pellicle of ocean lysozyme and preparation method |
| 08/31/2005 | CN1660417A Formula of raw material pollen cream of nourishing face and preparing method |
| 08/31/2005 | CN1660416A Method and application of preparing oral powder of insulin through microcapsule technique |
| 08/31/2005 | CN1660415A Admixture of enkephalin containing methionine and trilobate cinquefoil and application |
| 08/31/2005 | CN1660414A Stable preparation of interferon |
| 08/31/2005 | CN1660413A New aplication of interferon pastille in use for preparing medication of treating recurrent ulcer of oral cavity |
| 08/31/2005 | CN1660412A Method of preparing microsphere of ethoxyl copolymer PLGA in interferon poly acid |
| 08/31/2005 | CN1660411A Cream of liposome of interferon |
| 08/31/2005 | CN1660410A bFGF liposome and preparation method |
| 08/31/2005 | CN1660409A Technique for preparing injection of protein polyeptide |
| 08/31/2005 | CN1660408A Medicine to be taken after being mixed in liquor of possessing bearutified and-faced effects |
| 08/31/2005 | CN1660407A Liquid preparation containing penta peptide of thymus and preparing method |
| 08/31/2005 | CN1660406A Short peptide type nutriend emulsion inside bowel and producing method |
| 08/31/2005 | CN1660405A Technique of preparing injection of brain proteolytic products |
| 08/31/2005 | CN1660131A Oral taking preparation for aesthetic health care and preparation method |
| 08/31/2005 | CN1660060A Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia |
| 08/31/2005 | CN1217190C Modulation of smrl-nep interactions in cns disorders giving rise to mental disorders |
| 08/31/2005 | CN1216992C Immunomodulators |
| 08/31/2005 | CN1216913C Human interleukin-17 receptor sampling molecule fusion protein and coding gene and expression cell line |
| 08/31/2005 | CN1216910C Novel liver regeneration related protein, its code sequence and application |
| 08/31/2005 | CN1216909C Human cervical cancer suppressor protein, polynucleotide encoding the protein cell transformed with the polynucleotide and method |
| 08/31/2005 | CN1216900C Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 08/31/2005 | CN1216857C Aniline-derived ligands for thyroid receptor |
| 08/31/2005 | CN1216641C Monoclonal human matural antibodies |
| 08/31/2005 | CN1216639C Methods for treating pain |
| 08/31/2005 | CN1216638C Genes coding proteins for early liver development and their use indiagnosing and treating liver disease |
| 08/31/2005 | CN1216637C Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 08/31/2005 | CN1216636C Titanium slow-release composition |
| 08/31/2005 | CN1216635C Composition and method for curing diabetes |
| 08/31/2005 | CN1216605C Combination therapy for treatment of tumors |
| 08/30/2005 | US6936706 In vitro and in vivo diagnosis, immunization, and therapy of neoplastic tumors, particularly carcinomas, by means of specifically targeted analogue peptides containing amino acid sequences encompassing CDRs of different species |
| 08/30/2005 | US6936704 a nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro |
| 08/30/2005 | US6936695 Manufacture and expression of large structural genes |
| 08/30/2005 | US6936694 [Met--1, des-Cys1, des-Tyr2, des-Cys3]IFN- gamma polypeptide produced by a DNA sequence coding in a transformant organism, and such polypeptide having the characteristics of human immune interferon |
| 08/30/2005 | US6936693 Specific polypeptides, useful as nematocides |
| 08/30/2005 | US6936691 Secreted protein HCE3C63 |
| 08/30/2005 | US6936690 Molecules of the card-related protein family and uses thereof |
| 08/30/2005 | US6936689 Peptide antagonists of zonulin and methods for use of the same |
| 08/30/2005 | US6936688 Nucleotide sequences coding polypeptide for use in the treatment of leukemia, tumors, infections, autoimmune disease, and fibrotic disorders; wound healing agent |
| 08/30/2005 | US6936595 Tumour-specific vector for gene therapy |
| 08/30/2005 | US6936594 Gene therapy for cerebrovascular disorders |
| 08/30/2005 | US6936589 Concurrent administering of druh and hypotonic sugar solution |
| 08/30/2005 | US6936587 peptide of lysine-proline-serine-serine-proline-proline-glutamic acid-glutamic acid |
| 08/30/2005 | US6936586 interleukin 10 (IL-10) agonists; treatment of pancreatitis, arthritis, gout, allergies, inflammations and ischemias; polypeptides |
| 08/30/2005 | US6936585 Corticotropin releasing factor 2 receptor agonists |
| 08/30/2005 | US6936584 Mixed amylin activity compounds |
| 08/30/2005 | US6936583 coadministering a taxane and an oral bioavailability enhancing agent inhibitor of p-glycoprotein; preventing or reducing hypersensitivity or allergic reactions; anticancer agents |
| 08/30/2005 | US6936582 in vitro treatment to induce ectopic bone growth and promote survival of neurons; osteogenic protein (op); bone morphogenetic protein (bmp); glial cell derived neurotophic factor (gdnf); nerve growth factor (ngf) |
| 08/30/2005 | US6936467 Nucleotide sequences for use in the repair of genetic damage |
| 08/30/2005 | US6936452 Inhibitors of the inositol polyphosphate 5-phosphate SHIP2 molecule |
| 08/30/2005 | US6936451 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/30/2005 | US6936450 Nucleotide sequences coding polypeptide; for use in the treatment of cancer, nervous system, inflammation, asthma, autoimmune, arthritis, graft vs. host disease, liver, viral,hormone, cardiovascular and metabolic disorders |
| 08/30/2005 | US6936448 As additives for human nutritive compositions or immunotherapeutics for cancer |
| 08/30/2005 | US6936440 Selecting ligand agonists and antagonists |
| 08/30/2005 | US6936439 Given DNA sequence; Fc immunoglobulin region attached; transforming cell; use in treating obesity |
| 08/30/2005 | US6936435 Compositions and methods for regulating bacterial pathogenesis |
| 08/30/2005 | US6936431 Anticancer, antitumor agents; measuring farnesylation of cellular protein |
| 08/30/2005 | US6936424 Materials and methods for detection and treatment of breast cancer |
| 08/30/2005 | US6936423 Anti-LTNF for in vitro assay of biological toxins |
| 08/30/2005 | US6936288 Treating herpes zoster varicella by applying an extract of pokeweed berries as active ingredient; permeates the cells of the nerve sheath killing the virus without immune system support |
| 08/30/2005 | US6936276 For tissue regeneration, applying a multilayer biodegradable matrix of crosslinked proteins and/or polysaccharides, where each layer has porosity to accomodate living cells; bone, joint, cartilage repair |
| 08/30/2005 | US6936270 Orthopedic hardware with a sustained release device configured to release a compound over an extended period of time and is attachable to a portion of the body |